Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rybak

Showing results (291-300 of 2,584) with videos related to

Pageof 259
Sort By:
Experimental Cell Research|December 10, 1999
Natural and engineered cytotoxic ribonucleases: therapeutic potentialS M Rybak, D L Newton
Nature Biotechnology|May 20, 1999
Uncloaking RNasesS M Rybak, D L Newton
Pharmacotherapy|October 8, 1999
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin familyD R Foster, M J Rybak
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1993
A liposome based platelet substitute, the plateletsome, with hemostatic efficacyM E Rybak, L A Renzulli
Clinical Pharmacy|November 1, 1983
Additive toxicity in patients receiving vancomycin and aminoglycosidesM J Rybak, S C Boike
Indian Journal of Physiology and Pharmacology|July 1, 1996
Comparative effects of exercise training on transcription of antioxidant enzyme and the activity in old rat heartS M Somani, L P Rybak
Journal of the National Cancer Institute|December 5, 1998
Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growthD L Newton, S M Rybak
The Journal of Antimicrobial Chemotherapy|April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clotsS M Palmer, M J Rybak
Medycyna Wieku Rozwojowego|June 18, 2009
[Bone mineralization and childhood cancer]Katarzyna Muszyńska-Rosłan, Maryna Krawczuk-Rybak
Otolaryngologic Clinics of North America|October 1, 1993
Developmental ototoxicityC M Henley, L P Rybak
Pageof 259

Showing results (291-300 of 2,584) with videos related to

Sort By:
Pageof 259
Experimental Cell Research|December 10, 1999
Natural and engineered cytotoxic ribonucleases: therapeutic potentialS M Rybak, D L Newton
Nature Biotechnology|May 20, 1999
Uncloaking RNasesS M Rybak, D L Newton
Pharmacotherapy|October 8, 1999
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin familyD R Foster, M J Rybak
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1993
A liposome based platelet substitute, the plateletsome, with hemostatic efficacyM E Rybak, L A Renzulli
Clinical Pharmacy|November 1, 1983
Additive toxicity in patients receiving vancomycin and aminoglycosidesM J Rybak, S C Boike
Indian Journal of Physiology and Pharmacology|July 1, 1996
Comparative effects of exercise training on transcription of antioxidant enzyme and the activity in old rat heartS M Somani, L P Rybak
Journal of the National Cancer Institute|December 5, 1998
Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growthD L Newton, S M Rybak
The Journal of Antimicrobial Chemotherapy|April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clotsS M Palmer, M J Rybak
Medycyna Wieku Rozwojowego|June 18, 2009
[Bone mineralization and childhood cancer]Katarzyna Muszyńska-Rosłan, Maryna Krawczuk-Rybak
Otolaryngologic Clinics of North America|October 1, 1993
Developmental ototoxicityC M Henley, L P Rybak
Pageof 259